09 September 2020 : Clinical Research
Clinical Characteristics and Treatment Outcomes in Human Immunodeficiency Virus (HIV)-Infected Patients with Liver Abscess: A Retrospective Study of 53 Patients
Wei Zhang1AE, Hongwei Yu1BC, Na Luo2BC, Zhongjie Hu1AE*DOI: 10.12659/MSM.923761
Med Sci Monit 2020; 26:e923761
Table 4 Treatments and complications in 53 HIV-infected patients with LA.
| Variable | Total (n=53) | Improvement group (n=48) | Non-improvement group (n=5) | t or &*χ2 | p |
|---|---|---|---|---|---|
| Treatments (n, %) | |||||
| Medical treatment | 7 (13.21%) | 4 (8.33%) | 3 (60.00%) | 6.52 | 0.011 |
| Percutaneous drainage | 44 (83.02%) | 42 (87.5%) | 2 (40.00%) | 4.27 | 0.039 |
| Surgical drainage | 2 (3.77%) | 2 (4.17%) | 0 (0) | 0 | 1 |
| Complications (n, %) | |||||
| Sepsis | 11 (20.75%) | 9 (18.75%) | 2 (40.00%) | 0.287 | 0.592 |
| Septic shock | 5 (9.43%) | 3 (6.25%) | 2 (40.00%) | 2.733 | 0.098 |
| Pleural effusion | 24 (45.28%) | 20 (41.67%) | 4 (80.00%) | 1.361 | 0.243 |
| Ascites | 17 (32.08%) | 13 (27.08%) | 4 (80.00%) | 3.645 | 0.056 |
| Portal venous thrombosis | 6 (11.32%) | 6 (12.50%) | 0 (0) | 0.01 | 0.922 |
| Length of hospitalization, mean±SD (days) | 27.94±17.81 | 28.71±17.48 | 20.60±21.51 | 0.968 | 0.338 |